An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting
Küçük Resim Yok
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier Sci Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
11th European Breast Cancer Conference (EBCC) -- MAR 21-23, 2018 -- Barcelona, SPAIN
Anahtar Kelimeler
[No Keywords]
Kaynak
European Journal Of Cancer
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
92
